Successful Retreatment Using Pembrolizumab for Non–small-cell Lung Cancer After Severe Immune-related Hepatitis: A Case Report

Keigo Kobayashi, Ichiro Nakachi, Akifumi Mitsuishi, Daisuke Arai, Kaori Sakurai, Katsunori Masaki, Atsushi Chiyotani, Hidenori Takahashi, Toshiyuki Tahara, Kenzo Soejima

Research output: Contribution to journalArticle

Original languageEnglish
JournalClinical Lung Cancer
DOIs
Publication statusAccepted/In press - 2019 Jan 1

Keywords

  • Immune-related adverse events
  • Immunotherapy
  • NSCLC
  • PD-1 inhibitors
  • Severe hepatitis

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this